Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Arris issued U.S. patent for drug design technology

July 12, 1996

Arris, SKB to research protease inhibitors

July 5, 1996

ArQule, ICAgen collaborate on ion channel modulators

July 5, 1996

Gilead reports important discovery related to genetic code blocker research

July 5, 1996

Eotaxin receptor cloned: Possible implications for asthma research

July 5, 1996

Anergen, Organon to collaborate on RA treatment

July 5, 1996

ArQule obtains rights to Yale's alpha-ketoamide chemistry technology

July 5, 1996

Mitotix in-licenses p27 technology

July 5, 1996

Tripos' ChemSpace available for licensing soon

June 28, 1996

American Biogenetic Sciences obtains antibody technology from MRC

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...